Traws Pharma Inc [TRAW] stock prices are up 31.69% to $1.87 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TRAW shares have gain 33.57% over the last week, with a monthly amount glided 31.69%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Traws Pharma Inc [NASDAQ: TRAW] stock has seen the most recent analyst activity on March 01, 2022, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $7. Previously, Guggenheim started tracking the stock with Buy rating on May 18, 2021, and set its price target to $4. On March 01, 2018, H.C. Wainwright reiterated its Buy rating and revised its price target to $7.50 on the stock. Maxim Group downgraded its rating to a Hold. H.C. Wainwright initiated its recommendation with a Buy and recommended $6 as its price target on October 09, 2017. Laidlaw started tracking with a Buy rating for this stock on April 27, 2017, and assigned it a price target of $10. In a note dated July 01, 2015, Piper Jaffray upgraded an Overweight rating on this stock.
The stock price of Traws Pharma Inc [TRAW] has been fluctuating between $0.97 and $19.44 over the past year. Traws Pharma Inc [NASDAQ: TRAW] shares were valued at $1.87 at the most recent close of the market.
Analyzing the TRAW fundamentals
The Traws Pharma Inc [NASDAQ:TRAW] reported sales of 0.23M for trailing twelve months, representing a surge of 1.79%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at -110.22%, Pretax Profit Margin comes in at -736.83%, and Net Profit Margin reading is -736.83%. To continue investigating profitability, this company’s Return on Assets is posted at -6.67, Equity is 5.0 and Total Capital is -1.85.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5933 points at the first support level, and at 1.3167 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.3633, and for the 2nd resistance point, it is at 2.8567.
Ratios To Look Out For
It’s worth pointing out that Traws Pharma Inc [NASDAQ:TRAW]’s Current Ratio is 1.81. Also, the Quick Ratio is 1.81, while the Cash Ratio stands at 1.85. Considering the valuation of this stock, the price to sales ratio is 45.23, the price to book ratio is 1.58.
